AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16314338 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable Loop Recorder (ILR)
Number of subjects: 201
Study 16314338 — intervention group
Group type: COMPARATOR
Intervention: Conventional investigation and management
Number of subjects: 201
Study 15055205 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil 10 mg/day orally
Number of subjects: 0
Study 15055205 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil
Number of subjects: 0
Study 15055205 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil 10 mg/day
Number of subjects: 0
Study 15055205 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine therapy
Number of subjects: 0
Study 10388640 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion angiography or angioscopy
Number of subjects: 1305
Study 10388640 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised defects
Number of subjects: 1305
Study 10388640 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor non-revised defects
Number of subjects: 1305
Study 10388640 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical defects
Number of subjects: 1305
Study 8679366 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms
Number of subjects: 40
Study 8679366 — intervention group
Group type: COMPARATOR
Intervention: Morphine 0.2 mg
Number of subjects: 40
Study 1799473 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil plus interferon alfa‐2b
Number of subjects: 124
Study 1799473 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil alone
Number of subjects: 124
Study 1799473 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b maintenance therapy
Number of subjects: 124
Study 6428627 — intervention group
Group type: EXPERIMENTAL
Intervention: Episiotomy
Number of subjects: 181
Study 6428627 — intervention group
Group type: COMPARATOR
Intervention: No episiotomy
Number of subjects: 181
Study 6428627 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact perineum
Number of subjects: 181
Study 6428627 — intervention group
Group type: EXPERIMENTAL
Intervention: First degree tears
Number of subjects: 181
Study 6428627 — intervention group
Group type: EXPERIMENTAL
Intervention: Episiotomy after epidural anaesthesia
Number of subjects: 181
Study 28939407 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure condition (playing with a colourless and odourless jelly with hands)
Number of subjects: 66
Study 28939407 — intervention group
Group type: COMPARATOR
Intervention: Control condition (playing a board game)
Number of subjects: 66
Study 26945746 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthMap model (immediate arm)
Number of subjects: 710
Study 26945746 — intervention group
Group type: COMPARATOR
Intervention: Usual care (deferred arm)
Number of subjects: 710
Study 25548141 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (+diuretics as needed)
Number of subjects: 180
Study 25548141 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 180
Study 24396959 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal limbal conjunctival autograft combined with pterygium excision (group A)
Number of subjects: 63
Study 24396959 — intervention group
Group type: COMPARATOR
Intervention: Pterygium excision with exposed sclera (group B)
Number of subjects: 63
Study 20805524 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation for incident AD
Number of subjects: 1695
Study 18200040 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0
Study 18200040 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study 15690319 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 23
Study 14620246 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Knowledge of Results (KR) about ball path and final location
Number of subjects: 0
Study 14620246 — intervention group
Group type: COMPARATOR
Intervention: 50% KR deprivation
Number of subjects: 0
Study 14620246 — intervention group
Group type: COMPARATOR
Intervention: 100% KR deprivation
Number of subjects: 0
Study 10431100 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with pre-coseasonal treatment
Number of subjects: 48
Study 10431100 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with preseasonal treatment
Number of subjects: 48
Study 10431100 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with coseasonal treatment (highest maintenance dose)
Number of subjects: 48
Study 10431100 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 48
Study 9263496 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropil
Number of subjects: 0
Study 2128047 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive pill (placebo week)
Number of subjects: 15
Study 2128047 — intervention group
Group type: COMPARATOR
Intervention: Control (unmedicated menstrual cycle)
Number of subjects: 15
Study 375793 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic (50%) glucose
Number of subjects: 15
Study 375793 — intervention group
Group type: COMPARATOR
Intervention: Physiologic (0.9%) saline solution
Number of subjects: 15
Study 31813404 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsecured standing position
Number of subjects: 24
Study 31813404 — intervention group
Group type: COMPARATOR
Intervention: Seated secured position
Number of subjects: 24
Study 31375616 — intervention group
Group type: EXPERIMENTAL
Intervention: TV monitor advertising local current health‐related research
Number of subjects: 0
Study 27861199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 101
Study 27861199 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 101
Study 25887511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT) as a nursing intervention
Number of subjects: 0
Study 25887511 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study 25887511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT)
Number of subjects: 0
Study 23680181 — intervention group
Group type: EXPERIMENTAL
Intervention: Community engagement strategies
Number of subjects: 0
Study 23680181 — intervention group
Group type: EXPERIMENTAL
Intervention: Early meetings with stakeholders
Number of subjects: 0
Study 23680181 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative study methods
Number of subjects: 0
Study 21414216 — intervention group
Group type: EXPERIMENTAL
Intervention: Step Up counseling program plus usual care
Number of subjects: 52
Study 21414216 — intervention group
Group type: COMPARATOR
Intervention: Usual care treatment for depression, smoking, and physical activity promotion
Number of subjects: 52
Study 19568921 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids supplemented parenteral nutrition (0.8 g/kg/day soybean oil + 0.2 g/kg/day omega-3 FAs)
Number of subjects: 56
Study 19568921 — intervention group
Group type: COMPARATOR
Intervention: Standard soybean-oil based fat (1.0 g/kg/day omega-6 FAs)
Number of subjects: 56
Study 17760535 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-loaded dental implants (N = 18)
Number of subjects: 17
Study 17760535 — intervention group
Group type: COMPARATOR
Intervention: Delayed-loaded dental implants (N = 16)
Number of subjects: 17
Study 15023243 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel alone (group 1A/B)
Number of subjects: 52
Study 15023243 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel/trastuzumab (group 2)
Number of subjects: 52
Study 11433055 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 350
Study 11433055 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 350
Study 9663944 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 360
Study 9663944 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin-V
Number of subjects: 360
Study 9663944 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 360
Study 8796207 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy followed by surgery
Number of subjects: 601
Study 8796207 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 601
Study 2229852 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise training (five 45‐minute sessions per week, brisk walking at 62 +/‐ 2% VO2 max for 15 weeks)
Number of subjects: 36
Study 2229852 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise training
Number of subjects: 36
Study 2229852 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise group
Number of subjects: 36
Study 6107116 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam 10 mg three times daily
Number of subjects: 0
Study 6107116 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg three times daily
Number of subjects: 0
Study 6107116 — intervention group
Group type: COMPARATOR
Intervention: Placebo 1 capsule three times daily
Number of subjects: 0
Study 30731480 — intervention group
Group type: EXPERIMENTAL
Intervention: Range-of-motion exercise
Number of subjects: 36
Study 30731480 — intervention group
Group type: COMPARATOR
Intervention: Tactile stimulation
Number of subjects: 36
Study 31103126 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive stretching (PS)
Number of subjects: 50
Study 31103126 — intervention group
Group type: COMPARATOR
Intervention: Passive movement (PM)
Number of subjects: 50
Study 28759939 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie low-carbohydrate soy containing diet
Number of subjects: 45
Study 26254839 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4)
Number of subjects: 0
Study 26254839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23740912 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated basic sciences with clinical features
Number of subjects: 51
Study 23740912 — intervention group
Group type: COMPARATOR
Intervention: Segregated basic sciences from clinical features
Number of subjects: 51
Study 20606118 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive decongestion (higher doses of loop diuretics, greater fluid loss)
Number of subjects: 336
Study 20606118 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive decongestion (hemoconcentration)
Number of subjects: 336
Study 18284263 — intervention group
Group type: COMPARATOR
Intervention: Probiotics (various strains including Lactobacillus rhamnosus GG) administered for 1 or 2 months
Number of subjects: 13
Study 18284263 — intervention group
Group type: COMPARATOR
Intervention: Probiotics (Lactobacillus rhamnosus GG) administered perinatally to mothers and to infants for the first 6 months
Number of subjects: 13
Study 18284263 — intervention group
Group type: COMPARATOR
Intervention: L. acidophilus administered for the first 6 months of life
Number of subjects: 13
Study 18284263 — intervention group
Group type: COMPARATOR
Intervention: Probiotics (various strains)
Number of subjects: 13
Study 16815774 — intervention group
Group type: EXPERIMENTAL
Intervention: High fatigue condition
Number of subjects: 14
Study 16815774 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental fatigue
Number of subjects: 14
Study 14738128 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing with a fluoridated dentifrice three times a day (B)
Number of subjects: 5
Study 14738128 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of a 2% sodium fluoride gel and exposure to the oral cavity (F)
Number of subjects: 5
Study 14738128 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to the oral cavity (C+)
Number of subjects: 5
Study 14738128 — intervention group
Group type: COMPARATOR
Intervention: Negative controls (C‐)
Number of subjects: 5
Study 10946033 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 130
Study 10946033 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg/day
Number of subjects: 130
Study 10946033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 8984570 — intervention group
Group type: EXPERIMENTAL
Intervention: rubber‐band ligature, anal dilator and Kamillosan ointment
Number of subjects: 120
Study 8984570 — intervention group
Group type: COMPARATOR
Intervention: rubber‐band ligature alone
Number of subjects: 120
Study 8984570 — intervention group
Group type: COMPARATOR
Intervention: rubber‐band ligature and anal dilator and vaseline
Number of subjects: 120
Study 1773325 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia with continuous infusion of epidural fentanyl
Number of subjects: 17
Study 1773325 — intervention group
Group type: COMPARATOR
Intervention: Intermittent intramuscular morphine
Number of subjects: 17
Study 6182833 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous lumbar epidural analgesia for 24 hours
Number of subjects: 38
Study 6182833 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (thiopentone‐oxygen‐nitrous oxide‐alcuronium‐pethidine sequence with artificial ventilation)
Number of subjects: 38
Study 6182833 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative complications combined with hypoxaemia
Number of subjects: 38
Study 6182833 — intervention group
Group type: COMPARATOR
Intervention: Uneventful postoperative course
Number of subjects: 38
Study 30822317 — intervention group
Group type: EXPERIMENTAL
Intervention: Attending fewer than five antenatal care (ANC) visits
Number of subjects: 1073
Study 30822317 — intervention group
Group type: EXPERIMENTAL
Intervention: Prematurity
Number of subjects: 1073
Study 30822317 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature rupture of membranes
Number of subjects: 1073
Study 28133725 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT‐ILE
Number of subjects: 20
Study 28133725 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 20
Study 25481454 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy School and Drugs (HSD) program
Number of subjects: 3784
Study 23949074 — intervention group
Group type: EXPERIMENTAL
Intervention: Ai-Chi exercises in a swimming pool
Number of subjects: 23
Study 23949074 — intervention group
Group type: COMPARATOR
Intervention: Active arm and leg exercises combined with abdominal breathing exercises at home (Control)
Number of subjects: 23
Study 22916320 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG) 4.5 g/d for 12 weeks
Number of subjects: 60
Study 22916320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 18443819 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong crosstalk (attending to left-right orientation of objects)
Number of subjects: 0
Study 18443819 — intervention group
Group type: COMPARATOR
Intervention: Weak crosstalk (attending to object identity)
Number of subjects: 0
Study 17523513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with limbal relaxing incisions (LRI)
Number of subjects: 50
Study 17523513 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery only (control group)
Number of subjects: 50
Study 15968597 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I therapy
Number of subjects: 30
Study 11445099 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 415
Study 11445099 — intervention group
Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 415
Study 9722035 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin III (AT III)
Number of subjects: 42
Study 9722035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 8042458 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm tub bath
Number of subjects: 110
Study 8042458 — intervention group
Group type: COMPARATOR
Intervention: Control (no bath)
Number of subjects: 110
Study 2898622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 14
Study 2898622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 29898210 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 144
Study 29898210 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 144
Study 29898210 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 144
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral X-82 (50 mg alternate days)
Number of subjects: 35
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral X-82 (50 mg daily)
Number of subjects: 35
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral X-82 (100 mg alternate days)
Number of subjects: 35
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral X-82 (100 mg daily)
Number of subjects: 35
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral X-82 (200 mg daily)
Number of subjects: 35
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral X-82 (300 mg daily)
Number of subjects: 35
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral X-82 (all doses)
Number of subjects: 35
Study 28570723 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events attributed to X-82
Number of subjects: 35
Study 25065017 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-aided Assertive Community Treatment (FACT)
Number of subjects: 337
Study 25065017 — intervention group
Group type: COMPARATOR
Intervention: Community care
Number of subjects: 337
Study 23278647 — intervention group
Group type: EXPERIMENTAL
Intervention: Surinabant 20 mg
Number of subjects: 30
Study 23278647 — intervention group
Group type: EXPERIMENTAL
Intervention: Surinabant 60 mg
Number of subjects: 30
Study 23278647 — intervention group
Group type: EXPERIMENTAL
Intervention: Surinabant 5 mg
Number of subjects: 30
Study 23278647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 21263322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 24
Study 21263322 — intervention group
Group type: EXPERIMENTAL
Intervention: Noisy pressure support ventilation
Number of subjects: 24
Study 21263322 — intervention group
Group type: COMPARATOR
Intervention: Pressure-controlled ventilation
Number of subjects: 24
Study 18422764 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 40 mg twice daily
Number of subjects: 4172
Study 16968508 — intervention group
Group type: EXPERIMENTAL
Intervention: Push-and-pull enteroscopy (PPE)
Number of subjects: 52
Study 16968508 — intervention group
Group type: COMPARATOR
Intervention: Push enteroscopy (PE)
Number of subjects: 52
Study 14502133 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic circulatory arrest plus retrograde cerebral perfusion
Number of subjects: 38
Study 14502133 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic circulatory arrest alone
Number of subjects: 38
Study 10783347 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular fluid IL-6 concentrations at the time of oocyte retrieval
Number of subjects: 156
Study 10783347 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IL-8 concentrations at the time of embryo transfer
Number of subjects: 156
Study 10783347 — intervention group
Group type: COMPARATOR
Intervention: Serum TNF-alpha concentrations
Number of subjects: 156
Study 10783347 — intervention group
Group type: COMPARATOR
Intervention: Serum VEGF concentrations
Number of subjects: 156
Study 9349067 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg with droperidol 0.75 mg
Number of subjects: 94
Study 9349067 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg with droperidol 1.25 mg
Number of subjects: 94
Study 9349067 — intervention group
Group type: COMPARATOR
Intervention: Both treatment groups
Number of subjects: 94
Study 8455964 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient group cognitive therapy
Number of subjects: 102
Study 8455964 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 102
Study 8455964 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy in combination with relaxation training
Number of subjects: 102
Study 8455964 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list (WL) control condition
Number of subjects: 102
Study 8455964 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment conditions (including WL)
Number of subjects: 102
Study 8455964 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 102
Study 3816293 — intervention group
Group type: EXPERIMENTAL
Intervention: Mequitazine (5 mg twice daily for 14 days)
Number of subjects: 30
Study 3816293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3816293 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline
Number of subjects: 30
Study 3816293 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 30
Study 29727370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump
Number of subjects: 181
Study 29727370 — intervention group
Group type: COMPARATOR
Intervention: Control (no intra-aortic balloon pump)
Number of subjects: 181
Study 29727370 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of 11 randomized controlled trials
Number of subjects: 181
Study 26886637 — intervention group
Group type: EXPERIMENTAL
Intervention: PMC-PEG-DP
Number of subjects: 236
Study 26886637 — intervention group
Group type: EXPERIMENTAL
Intervention: PMC-NaP-DP
Number of subjects: 236
Study 26886637 — intervention group
Group type: EXPERIMENTAL
Intervention: PMC-PEG-SD
Number of subjects: 236
Study 26886637 — intervention group
Group type: EXPERIMENTAL
Intervention: PMC-NaP-SD
Number of subjects: 236
Study 24886228 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire assessing confidence and knowledge in managing CKD
Number of subjects: 78
Study 22584638 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium (0.15 mg/kg)
Number of subjects: 80
Study 22584638 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium (0.9 mg/kg)
Number of subjects: 80
Study 20215699 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad2HIF (hypoxia inducible factor-1alpha)
Number of subjects: 13
Study 20215699 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo control)
Number of subjects: 13